Chemed CHE Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect at other companies
Other financials
Where this comes from
Reported directly by Chemed in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.
The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Chemed's cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Chemed's cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect?
- Chemed (CHE) reported cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect of -5,765,900,000% in Q1 2026.
- How has Chemed's cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect changed year-over-year?
- Chemed's cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect decreased by 1190.5% year-over-year, from -446,800,000% to -5,765,900,000%.
- What does cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect mean?
- The net change in the total balance of cash, cash equivalents, and restricted cash during the reporting period, excluding the effects of foreign currency exchange rate fluctuations. This provides a clear view of the actual cash generation or consumption from operations, investing, and financing activities. It is the primary measure of the company's overall liquidity movement.